0.0000
0.0000
(0.00%)
As of February 12 at 3:00:00 PM EST. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Mariusz Olejniczak | Chief Executive Officer | -- | -- | -- |
| Dr. Katarzyna Suchoszek Ph.D. | Director f Operations | -- | -- | -- |
| Ms. Beata Pajak Eng., Ph.D. | Chief Scientific Officer | -- | -- | -- |
| Mr. Marek Sipowicz M.D., Ph.D. | Chief Medical Officer | -- | -- | -- |
WPD Pharmaceuticals Inc.
700 – 595 Burrard Street
Vancouver, BC V7X 1S8
Canada
- Sector:
- Healthcare
- Industry: Biotechnology
Description
WPD Pharmaceuticals Inc. does not have any significant operations. Previously, it was engaged in the research and development of medicinal products in the fields of oncology. The company is headquartered in Vancouver, Canada.
Corporate Governance
WPD Pharmaceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
RGBPP Regen BioPharma, Inc.
0.0651
0.00%
XRTX XORTX Therapeutics Inc.
0.9294
-1.13%
SNSE Sensei Biotherapeutics, Inc.
0.4888
+4.44%
BNTC Benitec Biopharma Inc.
10.01
-1.86%
OABI OmniAb, Inc.
3.6450
+2.10%
PSTV Plus Therapeutics, Inc.
1.2150
+8.48%
CELC Celcuity Inc.
12.75
+2.74%
LENZ LENZ Therapeutics, Inc.
24.89
+0.20%
LVTX LAVA Therapeutics N.V.
0.9050
-3.72%
PVLA Palvella Therapeutics, Inc.
18.47
+9.43%